Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cereno Scientific releases BioStock interview with CEO Sten R. Sörensen regarding CS014 advancing to clinical Phase I

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that a video interview by BioStock has been released with CEO Sten R. Sörensen, commenting on the approval by the EMA for a first-in-human Phase I trial of novel histone deacetylase inhibitor (HDACi) CS014, why this is such an important milestone for Cereno, and the potential of HDAC inhibition as a concept in cardiovascular disease.Watch here: Cereno Scientific brings novel cardiovascular disease candidate to the clinic (youtube.

LAUNCH OF VOLUNTARY OFFER AND COMMENCEMENT OF OFFER PERIOD FOR ALL ISSUED AND OUTSTANDING SHARES IN KYOTO GROUP AT NOK 24 PER SHARE; OFFER ACCEPTANCE DEADLINE AT 16:30 CET ON 27 June 2024.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Reference is made to the announcement made by Kyoto Group AS ("Kyoto" or the "Company") on 14 June 2024 concerning the transaction agreement entered into by the Company and GF I Kiln HoldCo AS (the "Offeror") regarding a directed share issue in the Company (the "Investment") combined with a recommended voluntary all-cash offer for all outstanding shares (the "

BioStock: Cereno's CEO – "CS014 adds potential for cardiovascular disease patients"

Cereno Scientific is a biotech company developing treatments for the number one killer in the world - cardiovascular disease. The company has been granted the approval from EMA to initiate a first-in-human phase I trial with candidate CS014 – a novel epigenetic HDAC inhibitor. Cereno’s CEO Sten R Sörensen stopped by the BioStock Studio to share more details about the news.Read the interview at biostock.se: Cereno's CEO: "CS014 adds potential for cardiovascular disease patients" - BioStock 

Notification of a change in holdings of shares and voting rights under chapter 9, section 10 of the Finnish Securities Market Act

LINDEX GROUP plc, Major shareholders announcements, 20.6.2024 at 8:30 EEST   Notification of a change in holdings of shares and voting rights under chapter 9, section 10 of the Finnish Securities Market Act   Lindex Group plc (the "Company") has received a notification, according to which Nordic Retail Partner JV Ky’s holding in the Company's shares and voting rights will decrease below 15 per cent as a result of the directed share issue of 2,599,852 new shares (the "Share Issue), which the Company announced through a stock exchange release on 19 June 2024.   1. Name of

Sweco supports VoltH2 in design and development of new green hydrogen plant in the Netherlands

The European energy company VoltH2 has selected Sweco as its partner for the design and development of a new hydrogen plant in Delfzijl in the Netherlands. The production facility has received the necessary permits and is currently in the design phase. The plant is expected to start producing approximately 5,000 tonnes of green hydrogen yearly from the second half of 2027 and will supply local industries.VoltH2 focuses on the development and operation of large-scale green hydrogen production plants across Europe with the aim of supplying the local industry and transportation sectors with

Read original

MPCC Announces Vessel Acquisitions and New Charter Package Deal

Oslo, Norway – MPC Container Ships ASA (“MPCC” or the “Company”) is pleased to announce the acquisition of two 3,500 TEU vessels and a charter agreement package for a total of 10 vessels, including the new acquisitions, thereby strengthening the Company’s backlog and improving earnings visibility. The acquisition consists of two 3,500 TEU vessels at a total price of USD 47.25 million. The vessels are expected to be handed over from their current owner in the third quarter of 2024 and will be delivered into pre-agreed firm 36-month time charter contracts with a top-tier liner company.

CapMan Residential Fund makes its second investment in Sweden through the acquisition of a forward funding project in Ursvik, Sundbyberg

CapMan Real Estate press release20.6.2024 at 08:00 AM EEST CapMan Residential Fund makes its second investment in Sweden through the acquisition of a forward funding project in Ursvik, Sundbyberg CapMan Residential Fund acquires a forward funding project in Ursvik, Sundbyberg. The project is situated 10 km north of Stockholm city center and comprises 289 rental apartments, an underground parking garage with 85 parking spaces and two small commercial premises. The project is acquired from Reliwe, and the development and construction will be managed by Reliwe and Consto with expected

Half of US and UK finance professionals hit by deepfake fraud scams

Half of finance professionals (53%) have been attacked with deepfake scamming attempts, with 43% admitting they have fallen victim to an attack according to new data from Medius, a leading provider of cloud-based accounts payable automation and spend management solutions.85% of respondents say deepfake technology poses an existential crisis to the business’ financial security.  Ahmed Fessi, Chief Transformation & Information Officer, explains: “Today’s CEOs and CFOs have large digital footprints. They have speeches, interviews and videos plastered across YouTube, LinkedIn and corporate

Artificial Solutions announces upsize and completes a directed share issue of approximately SEK 50 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.Artificial Solutions International AB (“Artificial Solutions” or the “Company”) has, in accordance with the intention announced in the Company’s press

Offer document regarding Goldcup 35626 AB’s (under name change to Notalp Logistik AB) voluntary public offer to the shareholders of Jetpak Top Holding AB (publ) made public

THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED "IMPORTANT

Goldcup 35626 AB (under name change to Notalp Logistik AB) announces a public offer to the shareholders of Jetpak Top Holding AB (publ)

THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED "IMPORTANT

Pak Logistik Intressenter AB is member of a consortium that today has announced a voluntary public offer to the shareholders of Jetpak Top Holding AB (publ)

THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE MANDATORY OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED "

Notice of extraordinary general meeting in BrightBid Group AB (publ)

The shareholders of BrightBid Group AB (publ), reg. no. 556710-8757 (the "Company"), are hereby invited to the Extraordinary General Meeting on Tuesday 23 July 2024 at 10:00 a.m. at Setterwalls Advokatbyrå at Sturegatan 10 in Stockholm. Registration for the meeting begins at 09:45. Notification of attendance Shareholders who wish to attend the meeting must: · be registered as a shareholder in the share register kept by Euroclear Sweden AB in respect of the circumstances on Monday 15 July 2024, and · not later than Wednesday 17 July 2024 have notified the Company of

Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures

Bioretec Ltd                    Press release                   19 June 2024 at 9:00 p.m. EESTBioretec Ltd., a pioneer in biodegradable orthopedic implants, is pleased to announce that a number of cases have been performed around the U.S. utilizing the RemeOs™ technology. The follow-up results confirmed successful implantation and fracture healing were achieved in all cases. Surgeons reported very positive feedback in that there is no change to existing surgical technique while operating with an absorbable metal implant for their patients. The added benefit of osteopromotion and bioactivity

Circio Holding ASA – Minutes from the annual general meeting 2024 and approval of Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Oslo, 19 June 2024: Circio Holding ASA (the "Company") held its annual general meeting today, 19 June 2024, as a physical meeting at the Company's offices at St. Olavs Plass 5, 0165 Oslo. All resolutions were made in accordance with the

Johan Stuart is leaving Sinch’s board of directors

Stockholm, Sweden – 19 juni 2024 – Sinch AB (publ), which is pioneering the way the world communicates through its Customer Communications Cloud, today announces that Johan Stuart is leaving the board of directors for personal reasons. The process of finding a successor will now be initiated. Johan Stuart has been a member of Sinch’s board of directors since 2015. "Sinch is today more than ten times larger than it was when Johan Stuart was elected as a new board member. I would like to thank Johan for his long-term commitment and valuable contribution to Sinch's development during this

Solstad Maritime Holding AS: Share capital increase registered

Skudeneshavn, June 19, 2024 - Reference is made to the stock exchange announcement published by Solstad Offshore ASA ("SOFF") on 12 June 2024 regarding the successful offering of 63,497,303 new shares in Solstad Maritime Holding AS ("SMH")(the "Offering"). The registration of the share capital relating to the Offering has been completed with the Norwegian Register of Business Enterprises. SMH's new registered share capital is NOK 93,071,711 divided into 465,358,555 shares, each with a nominal value of NOK 0.20. Each share represents one vote in SMH's general meeting. The shares are

Relais Group Plc: Share Repurchase 19.6.2024

Relais Group Plc  ANNOUNCEMENT  19.6.2024 Relais Group Plc: Share Repurchase 19.6.2024 In the Helsinki Stock Exchange Trade date           19.6.2024Bourse trade         BuyShare                  RELAISAmount             600 SharesAverage price/ share    13,6836 EURTotal cost            8 210,16 EUR Relais Group Plc now holds a total of 19 821 sharesincluding the shares repurchased on 19.6.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

Pihlajalinna Oyj: Acquisition of own shares on June 19, 2024

Pihlajalinna Oyj: Acquisition of own shares on June 19, 2024 Pihlajalinna Oyj’s stock exchange release on June 19, 2024, at 07:00 p.m. EET Date June 19, 2024Exchange transaction BuyShare trading code PIHLISAmount, shares 605Average price/share (EUR) 9.6957Total cost (EUR) 5,865.90 After the acquisitions Pihlajalinna Oyj holds a total of 137,660 treasury shares. ON BEHALF OF PIHLAJALINNA OYJ Danske Bank A/S, Finland Branch  Antti Väliaho                        Jonathan Nyberg Additional Information

There are no items matching the current filter
There are no more items matching the current filter
Back to top